SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026034
Filing Date
2017-05-10
Accepted
2017-05-10 16:06:33
Documents
37
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v466186_10q.htm 10-Q 249104
2 EXHIBIT 31.1 v466186_ex31-1.htm EX-31.1 9567
3 EXHIBIT 31.2 v466186_ex31-2.htm EX-31.2 9567
4 EXHIBIT 32.1 v466186_ex32-1.htm EX-32.1 4083
5 EXHIBIT 32.2 v466186_ex32-2.htm EX-32.2 3975
  Complete submission text file 0001144204-17-026034.txt   1586144

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20170331.xml EX-101.INS 193871
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20170331.xsd EX-101.SCH 19398
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20170331_cal.xml EX-101.CAL 35437
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20170331_def.xml EX-101.DEF 119445
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20170331_lab.xml EX-101.LAB 165154
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20170331_pre.xml EX-101.PRE 136610
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 17830242
SIC: 2836 Biological Products, (No Diagnostic Substances)